Calin Nicolescu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Magnetic Resonance

Small Cell Lung Cancer

Top Venues

Bioconjugate chemistry

Chemical & biomedical imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Calin Nicolescu, Jiyoon Kim, Da Sun, Zheng-Rong Lu
Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging. Bioconjugate chemistry 35 (3) (2024)
Calin Nicolescu, Jiyoon Kim, Da Sun, Zheng-Rong Lu
Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging. Bioconjugate chemistry 35 (3) (2024)
Calin Nicolescu, Jiyoon Kim, Da Sun, Zheng-Rong Lu
Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging. Bioconjugate chemistry (2024)
Calin Nicolescu, Jiyoon Kim, Da Sun, Zheng-Rong Lu
Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging. Bioconjugate chemistry 35 (3) (2024)
Calin Nicolescu, Andrew Schilb, Jiyoon Kim, Da Sun, Ryan Hall, Songqi Gao, Hannah Gilmore, William P Schiemann, Zheng-Rong Lu
Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging. Chemical & biomedical imaging 1 (5) (2023)
Calin Nicolescu, Amita Vaidya, Andrew Schilb, Zheng-Rong Lu
Regulating Oncogenic LncRNA DANCR with Targeted ECO/siRNA Nanoparticles for Non-Small Cell Lung Cancer Therapy. ACS omega 7 (26) (2022)